Global University Research Index

Sichuan University

Sichuan University longevity research profile: 15226 source-matched work links across 12 tracked topics, with transparent methodology and representative sources.

85.0Transparent research index score

15226Five-year longevity work links

12Longevity topics represented

36%Share indexed since 2025

100%Open-access representative sample

University website OpenAlex institution record ROR identity record

Chengdu, Sichuan, China. This profile is generated from OpenAlex work affiliations resolved against ROR institution identities.

Topic profile

Where the indexed activity appears

Compare universities

Exercise

4043 source-matched work links since 2022 · 1517 since 2025 · 3972 citations across the representative sample

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms · 2022 · 3972 OpenAlex citations · open access

4043

Stem cells

3745 source-matched work links since 2022 · 1163 since 2025 · 5471 citations across the representative sample

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms · 2022 · 3972 OpenAlex citations · open access
Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics · 2022 · 1499 OpenAlex citations · open access

3745

Sleep

3074 source-matched work links since 2022 · 1250 since 2025 · 1094 citations across the representative sample

Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies · 2024 · 1094 OpenAlex citations · open access

3074

Gene therapy

1259 source-matched work links since 2022 · 447 since 2025 · 5361 citations across the representative sample

Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics · 2022 · 1499 OpenAlex citations · open access
Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies · 2024 · 1094 OpenAlex citations · open access
Neoantigens: promising targets for cancer therapy · 2023 · 996 OpenAlex citations · open access
Vaccine adjuvants: mechanisms and platforms · 2023 · 925 OpenAlex citations · open access
Nanomedicine in cancer therapy · 2023 · 847 OpenAlex citations · open access

1259

Rapamycin

833 source-matched work links since 2022 · 264 since 2025 · 4405 citations across the representative sample

Targeted protein degradation: mechanisms, strategies and application · 2022 · 961 OpenAlex citations · open access
Vaccine adjuvants: mechanisms and platforms · 2023 · 925 OpenAlex citations · open access
Nanomedicine in cancer therapy · 2023 · 847 OpenAlex citations · open access
Signaling pathways and targeted therapy for myocardial infarction · 2022 · 847 OpenAlex citations · open access
Regulated cell death (RCD) in cancer: key pathways and targeted therapies · 2022 · 825 OpenAlex citations · open access

833

Metformin

683 source-matched work links since 2022 · 245 since 2025 · 4258 citations across the representative sample

Targeting TGF-β signal transduction for fibrosis and cancer therapy · 2022 · 1067 OpenAlex citations · open access
Signaling pathways and targeted therapy for myocardial infarction · 2022 · 847 OpenAlex citations · open access
Regulated cell death (RCD) in cancer: key pathways and targeted therapies · 2022 · 825 OpenAlex citations · open access
Kidney fibrosis: from mechanisms to therapeutic medicines · 2023 · 770 OpenAlex citations · open access
The Hippo signalling pathway and its implications in human health and diseases · 2022 · 749 OpenAlex citations · open access

683

Senolytics

664 source-matched work links since 2022 · 269 since 2025 · 3341 citations across the representative sample

Targeting TGF-β signal transduction for fibrosis and cancer therapy · 2022 · 1067 OpenAlex citations · open access
Oral squamous cell carcinomas: state of the field and emerging directions · 2023 · 800 OpenAlex citations · open access
Kidney fibrosis: from mechanisms to therapeutic medicines · 2023 · 770 OpenAlex citations · open access
Tumor biomarkers for diagnosis, prognosis and targeted therapy · 2024 · 704 OpenAlex citations · open access

664

GLP-1 therapies

349 source-matched work links since 2022 · 130 since 2025 · 2238 citations across the representative sample

Signaling pathways and targeted therapy for myocardial infarction · 2022 · 847 OpenAlex citations · open access
Kidney fibrosis: from mechanisms to therapeutic medicines · 2023 · 770 OpenAlex citations · open access
Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy · 2024 · 621 OpenAlex citations · open access

349

Caloric restriction

190 source-matched work links since 2022 · 67 since 2025 · 1039 citations across the representative sample

Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy · 2024 · 621 OpenAlex citations · open access
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications · 2023 · 418 OpenAlex citations · open access

190

Partial reprogramming

161 source-matched work links since 2022 · 70 since 2025 · 1758 citations across the representative sample

Tumor biomarkers for diagnosis, prognosis and targeted therapy · 2024 · 704 OpenAlex citations · open access
Targeting the tumor stroma for cancer therapy · 2022 · 363 OpenAlex citations · open access
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions · 2024 · 359 OpenAlex citations · open access
Macrophage plasticity: signaling pathways, tissue repair, and regeneration · 2024 · 332 OpenAlex citations · open access

161

Plasma exchange

140 source-matched work links since 2022 · 49 since 2025 · 612 citations across the representative sample

Acute Pancreatitis: Diagnosis and Treatment · 2022 · 612 OpenAlex citations · open access

140

Epigenetic clocks

85 source-matched work links since 2022 · 41 since 2025 · 0 citations across the representative sample

No representative work was retained in the current sample.